Platelet-Rich Plasma Intramuscular Injections - Antinociceptive Therapy in Myofascial Pain Within Masseter Muscles in Temporomandibular Disorders Patients: A Pilot Study

Aleksandra Nitecka-Buchta, Karolina Walczynska-Dragon, Wojciech Michal Kempa, Stefan Baron, Aleksandra Nitecka-Buchta, Karolina Walczynska-Dragon, Wojciech Michal Kempa, Stefan Baron

Abstract

Background and Objective: The objective of this study was to explore the nociceptive effect of platelet-rich plasma (PRP) intramuscular injections in myofascial pain of masseter muscles in patients with TMD. Methods: Patients diagnosed with myofascial pain were assessed for eligibility for the study. Masticatory muscle disorder was diagnosed based on the Research Diagnostic Criteria for Temporomandibular Disorders (Ia and Ib). A total of 80 patients were enrolled in the study; 58 of them (21 male and 37 female, 29.4 ± 6.53 years old) met the inclusion criteria and were randomized to one of the two groups: Group I (n = 29) and Group II (n = 29). The first group received injections with PRP and the second group received injections with isotonic saline as the control group (0.9% NaCl). The Visual Analog Scale (VAS) was used to determine the pain intensity changes during follow-up visits in each group. Results: A significant improvement in pain intensity in VAS scale was observed, with 58% reduction in the experimental group and 10.38% in the control placebo group, 5 days after the injections (Day 5). The pain intensity reduction (VAS) 14 days after the injections (Day 14) in experimental group was 47.16 and 4.62% in control group, according to the baseline values (Day 0). Conclusions: Intramuscular injection of PRP was a successful method for reducing myofascial pain within masseter muscles in temporomandibular disorders patients. However, the use of PRP for the treatment of myofascial pain within masticatory muscles requires further, clinical trials evaluation. Clinical Trial Registration: Bioethical Commission at the Silesian Medical Chamber in Katowice, Poland 44/2017 as well as at ClinicalTrials.gov NCT03323567 (December 13, 2017).

Keywords: intramuscular injection; masseter muscle; muscle regeneration; myofascial pain; platelet-rich plasma.

Figures

Figure 1
Figure 1
The two-arm diagram of the flow of participants in the study.
Figure 2
Figure 2
Pain intensity changes in VAS—average values: baseline visit (Day 0), control 1 (Day 5), and control 2 (Day 14).
Figure 3
Figure 3
Pain level in VAS, Group I-platelet-rich plasma (Day 0, 5, and 14).
Figure 4
Figure 4
Pain level in VAS, Group II-placebo (Day 0, 5, and 14).

References

    1. Dhurat R, Sukesh M. Principles and methods of preparation of platelet-rich plasma: a review and author's perspective. J Cutan Aesthet Surg. (2014) 7:189–97. 10.4103/0974-2077.150734
    1. Akhundov K, Pietramaggiori G, Waselle L, Darwiche S, Guerid S, Scaletta C, et al. . Development of a cost-effective method for platelet-rich plasma (PRP) preparation for topical wound healing. Ann Burns Fire Disasters. (2012) 25:207–13.
    1. Dohan Ehrenfest DM, Rasmusson L, Albrektsson T. Classification of platelet concentrates: from pure platelet-rich plasma (P-PRP) to leucocyte- and platelet-rich fibrin (L-PRF). Trends Biotechnol. (2009) 27:158–67. 10.1016/j.tibtech.2008.11.009
    1. Pihut M, Szuta M, Ferendiuk E, Zenczak-Wieckiewicz D. Evaluation of pain regression in patients with temporomandibular dysfunction treated by intra-articular platelet-rich plasma injections: a preliminary report. Biomed Res Int. (2014) 2014:132369. 10.1155/2014/132369
    1. Lin SL, Tsai CC, Wu SL, Ko SY, Chiang WF, Yang JW. Effect of arthrocentesis plus platelet-rich plasma and platelet-rich plasma alone in the treatment of temporomandibular joint osteoarthritis: A retrospective matched cohort study (A STROBE-compliant article). Medicine. (2018) 97:e0477. 10.1097/MD.0000000000010477
    1. Reurink G, Goudswaard GJ, Moen MH, Weir A, Verhaar JA, Bierma-Zeinstra SM, et al. . Platelet-rich plasma injections in acute muscle injury. N Engl J Med. (2014) 370:2546–7. 10.1056/NEJMc1402340
    1. Osiewicz MA, Lobbezoo F, Loster BW, Wilkosz M, Naeije M. Badawcze Kryteria Diagnostyczne Zaburzen Czynnościowych Układu Ruchowego Narzadu Zucia BKD/ZCURNZ—polska wersja dwuosiowego systemu diagnostycznego ZCURNZ. J Stomatol. (2013) 576–649.
    1. American Academy of Sleep Medicine International Classification of Sleep Disorders. 3rd ed. Darien, IL: American Academy of Sleep Medicine; (2014).
    1. Martynowicz H, Dymczyk P, Dominiak M, Kazubowska K, Skomro R, Poreba R, et al. . Evaluation of intensity of sleep bruxism in arterial hypertension. J Clin Med. (2018) 7:E327. 10.3390/jcm7100327
    1. Osiewicz MA, Lobbezoo F, Loster BW, Loster JE, Manfredini D. Frequency of temporomandibular disorders diagnoses based on RDC/TMD in a Polish patient population. Cranio. (2018) 36:304–10. 10.1080/08869634.2017.1361052
    1. Setayesh K, Villarreal A, Gottschalk A, Tokish JM, Choate WS. Treatment of muscle injuries with platelet-rich plasma: a review of the literature. Rev Musculoskelet Med. (2018) 11:635–42. 10.1007/s12178-018-9526-8
    1. Antes G. The new CONSORT statement. BMJ. (2010) 340:c332. 10.1136/bmj.c1432
    1. Ceci C, Niada S, Del Fabbro M, Lolato A, Taschieri S, Giannasi C, et al. . Does freeze-thawing influence the effects of platelet concentrates? An in vitro study on human adipose-derived stem cells. J Craniofac Surg. (2016) 27:398–404. 10.1097/SCS.0000000000002428
    1. Mazzocca AD, McCarthy MB, Chowaniec DM, Cote MP, Romeo AA, Bradley JP, et al. . Platelet-rich plasma differs according to preparation method and human variability. J Bone Joint Surg Am. (2012) 94:308–16. 10.2106/JBJS.K.00430
    1. Bernuzzi G, Petraglia F, Pedrini MF, De Filippo M, Pogliacomi F, Verdano MA, et al. . Use of platelet-rich plasma in the care of sports injuries: our experience with ultrasound-guided injection. Blood Transfus. (2014) 12 (Suppl. 1):s229–34. 10.2450/2013.0293-12
    1. Franchini M, Cruciani M, Mengoli C, Marano G, Pupella S, Veropalumbo E, et al. . Efficacy of platelet-rich plasma as conservative treatment in orthopaedics: a systematic review and meta-analysis. Blood Transfus. (2018) 16:502–13. 10.2450/2018.0111-18
    1. Hamid MS, Mohamed Ali MR, Yusof A, George J, Lee LP. Platelet-rich plasma injections for the treatment of hamstring injuries: a randomized controlled trial. Am J Sports Med. (2014) 42:2410–8. 10.1177/0363546514541540
    1. Martinez-Zapata MJ, Orozco L, Balius R, Soler R, Bosch A, Rodas G, et al. . Efficacy of autologous platelet-rich plasma for the treatment of muscle rupture with haematoma: a multicentre, randomised, double-blind, placebo-controlled clinical trial. Blood Transfus. (2016) 14:245–54. 10.2450/2015.0099-15
    1. Tsai WC, Yu TY, Chang GJ, Lin LP, Lin MS, Pang JS. Platelet-rich plasma releaseate promotes regeneration and decreases inflammation and apoptosis of injured skeletal muscle. Am J Sports Med. (2018) 46:1980–6. 10.1177/0363546518771076
    1. Hammond JW, Hinton RY, Curl LA, Muriel JM, Loverin RM. Use of autologous platelet-rich plasma to treat muscle strain injuries. Am J Sports Med. (2009) 37:1135–42. 10.1177/0363546508330974

Source: PubMed

Sponsors et collaborateurs

Les conditions médicales

Interventions en matière de drogue

3
S'abonner